ライフサイエンスコーパス: urologic

1 nt noncardiac surgery, with abdominal (36%), urologic (21%), orthopedic (15%), and vascular being mos

2 end-stage renal failure as a consequence of urologic abnormalities (mean age 32 years).

3 ssue of radiologic evaluation for underlying urologic abnormalities following a urinary tract infecti

4 , we look at the most recent findings in the urologic and psychiatric literature and try to piece tog

5 c, plastic, podiatric, thoracic, transplant, urologic, and peripheral vascular.

6 because of the high incidence of associated urologic anomalies.

7 This article details the diverse urologic applications of tissue glues and hemostatic age

8 nical translational research directed toward urologic applications.

9 he European Association of Urology, American Urologic Association, International Continence Society,

10 The pan-urologic cancer genomic subtypes would facilitate inform

11 -hospital mortality after two of three major urologic cancer procedures is affected only by procedure

12 d translate into better outcomes after major urologic cancer surgery.

13 Comparison of outcome after three major urologic cancer-related surgical procedures (radical cys

14 enal cell carcinoma (RCC) is the most lethal urologic cancer.

15 Here, we show that 1954 urologic cancers can be classified into nine major genom

16 ogist is associated with lower mortality for urologic cancers in that county, but increasing urologis

17 Urologic cancers include cancers of the bladder, kidney,

18 h-volume centers - lymph node dissection for urologic cancers is equivalent between open and minimall

19 ecause they are the first care providers for urologic cancers, can easily be identified from availabl

20 arcinoma (RCC) is one of the most aggressive urologic cancers, however, the mechanism on supporting R

21 roductive technology may allow men to bypass urologic care in order to achieve their family planning

22 disease (AOR, 1.65), black race (AOR, 0.44), urologic cause of ESRD (AOR, 0.57), age >85 years (AOR,

23 placebo-controlled trial was conducted at 20 urologic clinics to evaluate the effects of sildenafil t

24 widely diagnosed conditions in men attending urologic clinics.

25 veillance is gaining wider acceptance in the urologic community as an effective treatment option for

26 yperplasia with increased attention from the urologic community in recent years.

27 dardization of pelvic lymphadenectomy in the urologic community is strongly needed.

28 continued to rapidly disseminate through the urologic community, but the ultimate impact remains unde

29 chniques are safely adaptable in the broader urologic community.

30 pathologic conditions increased the risk of urologic complication and vesicoureteral reflux.

31 Because of the high urologic complication rates, careful surveillance of low

32 study was to compare the incidence of major urologic complications (MUCs: urinary leak and ureteric

33 Nine (6.1%) patients had urologic complications and seven (4.8%) patients develop

34 Posttransplant urologic complications are associated with substantially

35 Although urologic complications are higher when kidneys are trans

36 Urologic complications can be avoided.

37 Urologic complications cause substantial morbidity in th

38 Patients with urologic complications had equivalent graft survival, bu

39 by LDN, and a potential higher incidence of urologic complications in LDN transplant recipients.

40 There have been no short-or long-term urologic complications in this series.

41 may have utility in reversing the secondary urologic complications of type 2 diabetes.

42 surgery is associated with increased risk of urologic complications posttransplant.

43 t, it is associated with a high frequency of urologic complications, including urinary tract infectio

44 ysfunctional lower urinary tract experienced urologic complications.

45 ificantly fewer urinary tract infections and urologic complications.

46 nd stent use did not affect the incidence of urologic complications.

47 hange may be important in the development of urologic conditions in aging men.

48 Many urologic conditions that necessitate reconstructive surg

49 Many urologic conditions that require reconstructive surgery

50 ring that of extirpative surgery for certain urologic conditions.

51 Since its initial urologic description in 2007, there has been a surge of

52 on is critical for the child with associated urologic disease and end-stage renal disease.

53 is the most frequently diagnosed kidney and urologic disease and Escherichia coli is by far the most

54 is the most frequently diagnosed kidney and urologic disease, and Escherichia coli is by far the mos

55 asive techniques have been widely applied to urologic diseases affecting the upper and lower urinary

56 Urolithiasis is one of the most common urologic diseases in industrialized societies.

57 ductive failure may be a harbinger of future urologic diseases, including prostate cancer (CaP), thus

58 ic antagonist for the treatment of pediatric urologic disorders has expanded greatly over the past de

59 stinctive urinary crystals and a spectrum of urologic disorders were noted in patients receiving indi

60 he endoscopic treatment of a wide variety of urologic disorders.

61 n the treatment of benign and some malignant urologic disorders.

62 91 eligible patients, 85 underwent complete urologic evaluation and 68 (75%; 95% confidence interval

63 thus emphasizing the importance of dedicated urologic evaluation and care for all male infertility pa

64 Mean number of years between urologic evaluation and herniorrhaphy was 6.3 years.

65 DVICE 4: Clinicians should refer for further urologic evaluation in all adults with gross hematuria,

66 After complete urologic evaluation, operable patients who achieved comp

67 This review critically assesses some of the urologic evaluations in patients who have undergone feta

68 sion before 35 years of age: 2 points; first urologic event before 35 years of age: 2 points; PKD2 mu

69 yed their widespread implementation into the urologic field.

70 Men with PI-RADS categories 1-2 remained in urologic follow-up for at least 2 years, with rebiopsy (

71 The importance of associated urologic, gynecologic, neurologic, and orthopedic malfor

72 rom 86.0% for orthopedic surgery to 53.8% in urologic/gynecologic and 53.6% in other procedures.

73 13 patients with abnormal VCUGs had a prior urologic history.

74 orthopedic, neurosurgical, gynecologic, and urologic) in adult patients with low surgical risk (defi

75 high likelihood of calculi who would require urologic intervention within 90 days.

76 all, 46 of 264 (17.4%) of patients underwent urologic intervention, and 25 of 108 (23.1%) patients wh

77 ion regimens, the role of minimally invasive urologic intervention, and the recent insights into the

78 identify patients in the ED who will require urologic intervention.

79 ts who underwent reduced-dose CT underwent a urologic intervention; all were correctly diagnosed on t

80 to improve performance of a wider variety of urologic interventions beyond the standard minimally inv

81 Image-guided surgery (IGS) for abdominal and urologic interventions presents complex engineering and

82 outcomes is an underexplored area within the urologic literature and can provide an insight into a pa

83 To review the recent urologic literature with a focus on refinements of surgi

84 rt site metastasis have been reported in the urologic literature.

85 on, optimal management of, and screening for urologic malignancies in kidney transplant patients is w

86 he incidence, surveillance, and treatment of urologic malignancies in kidney transplant recipients.

87 rm complications of transplantation, such as urologic malignancies, have become increasingly importan

88 Excluding procedures for gynecologic/urologic malignancies, the proportion of procedures perf

89 ging, detection and treatment monitoring for urologic malignancies.

90 est for survivors of upper GI, leukemia, and urologic malignancies.

91 an independent factor for the development of urologic malignancy after KT.

92 All KT recipients who developed urologic malignancy from January 1, 1999, to December 31

93 High urologic malignancy incidence has been reported in end-s

94 The cumulative urologic malignancy incidence rate was significantly hig

95 pients tended to have a significantly higher urologic malignancy risk after KT.

96 Incidence rate ratio of urologic malignancy was significantly higher in female r

97 e relative odds (odds ratios) of an abnormal urologic measure in men with high versus low serum IGF-I

98 Urologic measures were assessed from the International P

99 stment for IGF-I and age, but not with other urologic measures.

100 cell carcinoma remains a major challenge for urologic oncologists.

101 otic surgery has gained a strong foothold in urologic oncology, gynecologic oncology, cardiothoracic

102 of minimally invasive surgical techniques in urologic oncology, the efficacy, safety, and adequacy of

103 d in the less chaotic arena of, for example, urologic oncology.

104 om 324 study centres (ie, hospitals or large urologic or group outpatient offices) in 43 countries.

105 tions in probands and FDRs who were blind to urologic or psychiatric diagnoses in the proband.

106 an operation performed by general, vascular, urologic, or cardiac surgery services between fiscal yea

107 Contrariwise, 1297 patients undergoing urologic, orthopedic, breast, and skin operations had mo

108 the effects of such a repair with respect to urologic outcome.

109 een hormone variables and rates of change in urologic outcomes were assessed with linear regression m

110 Annual changes in hormone levels and urologic outcomes were calculated using mixed-effects re

111 s contribute to the rates of change in these urologic outcomes.

112 ested possible central processes involved in urologic pain conditions similar to systemic pain syndro

113 Urologic pain conditions such as chronic prostatitis/chr

114 to map different phenotypes in patients with urologic pain conditions to tailor more effective therap

115 Domain characterization of urologic pain conditions via phenotype mapping can be us

116 nt literature on phenotype classification in urologic pain patients and their use in providing effect

117 In 2005, the International Society of Urologic Pathology consensus conference recommended that

118 following the 2005 International Society of Urologic Pathology consensus conference, AS may be appro

119 a major cause of morbidity and anxiety among urologic patients.

120 Urologic physiologic examinations were performed.

121 onditions traditionally outside the scope of urologic practice but important for the care of men with

122 1987 and 1997, when screening became routine urologic practice in the United States.

123 s are being increasingly employed in current urologic practice.

124 well characterized by direct interview, the urologic problems had been found only via medical histor

125 ly more likely to have PD, thyroid disorder, urologic problems, and any of the syndrome disorders (co

126 rated that CT is the test of choice for many urologic problems, including urolithiasis, renal masses,

127 nists in the management of various pediatric urologic problems.

128 ency department visit, hospitalization, or a urologic procedure to investigate or manage gross hematu

129 icted worse outcomes and performing an early urologic procedure was a protective measure.

130 ption in early 2000, robotic assistance with urologic procedures continues to expand.

131 strointestinal anastomoses, plastic surgery, urologic procedures including heminephrectomy, and other

132 ospitals performing a high volume of general urologic procedures or unrelated complex procedures may

133 ncy department visits, hospitalizations, and urologic procedures to manage gross hematuria).

134 virtually all extirpative and reconstructive urologic procedures.

135 apply them to the application of robotics to urologic procedures.

136 at which they were seen by a combination of urologic, radiation, and medical oncologists in a concur

137 Previous urologic reconstruction and pretransplant ureteral patho

138 obotic surgeons have described techniques in urologic reconstruction.

139 and the need for versatility in vascular and urologic reconstructions.

140 Recent changes in pediatric urologic reconstructive surgery are discussed in the pre

141 th particular emphasis on considerations for urologic referral.

142 unity-based Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) registry and 19,265

143 data to the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) registry.

144 ed from the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE), a disease registry

145 racted from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE), patients were comp

146 unity-based Cancer of the Prostate Strategic Urologic Research Endeavor [CaPSURE]; enrolled 1995 thro

147 ting in the Cancer of the Prostate Strategic Urologic Research Endeavor and who were followed for an

148 As laparoscopic training is integrated into urologic residency programs, standardizing the variables

149 e purpose of this study is to review current urologic robots and present future development direction

150 yond the standard minimally invasive robotic urologic surgeries conducted currently with the da Vinci

151 positive associations with burnout were: (1) urologic surgery (OR 1.497, P = 0.0086), (2) having 31%

152 To review optical imaging technologies in urologic surgery aimed to facilitate intraoperative imag

153 nd platforms designed for minimally invasive urologic surgery and their design rationale and potentia

154 acic, neurosurgery, orthopedic, general, and urologic surgery had received the Checklist.

155 The use of robotics in urologic surgery has seen exponential growth over the la

156 e feasibility and outcomes of reconstructive urologic surgery in older adults.

157 Prior urologic surgery is associated with increased risk of ur

158 The field of reconstructive pediatric urologic surgery is constantly changing.

159 tted to the general, vascular, thoracic, and urologic surgery services were monitored for the develop

160 gies that have reached the clinical arena in urologic surgery were reviewed, including photodynamic d

161 Robotic urologic surgery, an exciting and new emerging frontier

162 n of this technology to the armamentarium of urologic surgery.

163 ral epithelial cells obtained at the time of urologic surgery.

164 al surgery, peripheral vascular surgery, and urologic surgery.

165 the cost-effectiveness of using robotics in urologic surgery.

166 nique within the field of minimally invasive urologic surgery.

167 ale and potential roles in advancing current urologic surgical practice.

168 l manuscripts on a variety of robot-assisted urologic surgical procedures in children were identified

169 the evidence suggests that S repens improves urologic symptoms and flow measures.

170 ic antigen level and the association between urologic symptoms and prostate volume-results from the o

171 ant questions related to prostate cancer and urologic symptoms in a data set with missing values.

172 tween over-the-counter NSAID use and certain urologic symptoms, particularly among women with arthrit

173 ess questions related to prostate cancer and urologic symptoms.

174 patients receiving indinavir (8%) developed urologic symptoms.

175 es, and clinical evaluation of patients with urologic symptoms.

176 on, acute (grade 3 or 4) gastrointestinal or urologic toxicities occurred in 66 with cisplatin (19.1%

177 The frequency and longevity of urologic toxicity associated with cyclophosphamide thera

178 iocellular carcinoma (CCC; n = 40, 8.0%), or urologic tumors (URO; n = 14, 2.8%).

179 olangiocellular carcinoma [n = 40, 8.0%], or urologic tumors [n = 14, 2.8%]).

180 Thermal ablation of urologic tumors in the form of freezing (cryoablation) a